Kalergis David G 4
4 · Diffusion Pharmaceuticals Inc. · Filed Jan 30, 2020
Insider Transaction Report
Form 4
Kalergis David G
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-01-02+262,900→ 262,900 totalExercise: $0.46Exp: 2030-01-31→ Common Stock (262,900 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2020.